about
A proteomic approach for the identification of vascular markers of liver metastasis.Improved protein sequence coverage by on resin deglycosylation and cysteine modification for biomarker discovery.DeepQuanTR: MALDI-MS-based label-free quantification of proteins in complex biological samples.From target discovery to clinical trials with armed antibody products.Identification of E-cadherin signature motifs functioning as cleavage sites for Helicobacter pylori HtrAChemical proteomic and bioinformatic strategies for the identification and quantification of vascular antigens in cancer.Data Independent Acquisition of HLA Class I Peptidomes on the Q Exactive Mass Spectrometer Platform.Sarcoma Eradication by Doxorubicin and Targeted TNF Relies upon CD8+ T-cell Recognition of a Retroviral Antigen.Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes.High-resolution analysis of the murine MHC class II immunopeptidome.In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy.The MHC Class II Immunopeptidome of Lymph Nodes in Health and in Chemically Induced Colitis.High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera.A novel reactive ester derivative of biotin with reduced membrane permeability for in vivo biotinylation experiments.Purification of soluble HLA class I complexes from human serum or plasma deliver high quality immuno peptidomes required for biomarker discovery.Membranal and blood-soluble HLA class II peptidome analyses using data-dependent and independent acquisition.Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies.A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development.Antibody-based delivery of TNF to the tumor neo-vasculature potentiates the therapeutic activity of a peptide anti-cancer vaccineProteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathyThe accessible cerebral vascular proteome in a mouse model of cerebral β-amyloidosisIntron retention is a source of neoepitopes in cancer.T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patientsAntibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice
P50
Q30968545-74FCA841-6F0A-4AF7-9907-01664DAEBA5AQ33399161-780D3167-3363-4948-AFAC-CD3898D1EFC6Q33573770-50A2A8A8-D518-4742-9E55-214D978E0292Q35121334-23854B32-F1B2-46FF-8DAF-76A107DBD0EFQ35959929-A4FC04B8-0FB0-4F36-9BE1-0B7C1FEC6AD1Q37764177-3098827D-6943-49D6-B725-D7AE7325C761Q38611717-5FDD99E2-1C8E-4187-A9E4-86B0D517AB5CQ38704265-5A58A392-719A-4BEA-A3A5-9850B0B4FA0CQ38740015-BE564E8D-3F8B-40D9-AC6D-A5DED9CDC7ADQ38825612-CEC7ED6A-BA1E-4AFF-BEB9-988CEDD7444FQ39776451-1AD4F5AB-6A42-44A6-86A4-C7F3EFDE0D30Q41410098-4302A59C-8C36-4689-AB0F-3A9C5CE76B80Q41410124-5A30ECE7-2709-4F48-B3EB-B8E68F28969AQ42915350-55AD85B5-7845-4963-B468-F8D7038FABBDQ47158142-411ABE07-EC3E-4AC6-B068-241478853C24Q47191093-F1244098-BC4C-448E-813B-549388101EF3Q51770310-94731941-3188-4C89-BE5B-D87FCBDB1C2CQ53068456-2577F469-6B5E-44D7-9CCD-A2C20EB608FEQ57456567-516E91C5-985E-4F48-B9F1-1EE94B14E63AQ57912000-57E7DCD9-DD8A-473A-BE9B-0431C1696E0AQ57912002-34A6F31B-B843-4E1A-81A6-E4DFCC084EC3Q64990890-58FAABBE-F12E-4A91-99A2-4BA78B8E55ECQ91333564-E410B33D-DBF3-410B-9E28-FB0BB92BFD56Q92859626-FF4E3E47-4F31-4508-9C7B-1D1F81C0DFB1
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tim Fugmann
@ast
Tim Fugmann
@en
Tim Fugmann
@es
Tim Fugmann
@fr
Tim Fugmann
@nl
Tim Fugmann
@sl
type
label
Tim Fugmann
@ast
Tim Fugmann
@en
Tim Fugmann
@es
Tim Fugmann
@fr
Tim Fugmann
@nl
Tim Fugmann
@sl
prefLabel
Tim Fugmann
@ast
Tim Fugmann
@en
Tim Fugmann
@es
Tim Fugmann
@fr
Tim Fugmann
@nl
Tim Fugmann
@sl
P106
P21
P31
P496
0000-0002-7447-7480